Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk.

Muriel, Alfonso; Jiménez, David; Aujesky, Drahomir; Bertoletti, Laurent; Decousus, Herve; Laporte, Silvy; Mismetti, Patrick; Muñoz, Francisco J; Yusen, Roger; Monreal, Manuel (2014). Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk. Journal of the American College of Cardiology, 63(16), pp. 1675-1683. Elsevier 10.1016/j.jacc.2014.01.058

[img] Text
1-s2.0-S0735109714011711-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (481kB)

OBJECTIVES

The purpose of this study was to investigate the survival effects of inferior vena cava filters in patients with venous thromboembolism (VTE) who had a significant bleeding risk.

BACKGROUND

The effectiveness of inferior vena cava filter use among patients with acute symptomatic VTE and known significant bleeding risk remains unclear.

METHODS

In this prospective cohort study of patients with acute VTE identified from the RIETE (Computerized Registry of Patients With Venous Thromboembolism), we assessed the association between inferior vena cava filter insertion for known significant bleeding risk and the outcomes of all-cause mortality, pulmonary embolism (PE)-related mortality, and VTE rates through 30 days after the initiation of VTE treatment. Propensity score matching was used to adjust for the likelihood of receiving a filter.

RESULTS

Of the 40,142 eligible patients who had acute symptomatic VTE, 371 underwent filter placement because of known significant bleeding risk. A total of 344 patients treated with a filter were matched with 344 patients treated without a filter. Propensity score-matched pairs showed a nonsignificant trend toward lower risk of all-cause death for filter insertion compared with no insertion (6.6% vs. 10.2%; p = 0.12). The risk-adjusted PE-related mortality rate was lower for filter insertion than no insertion (1.7% vs. 4.9%; p = 0.03). Risk-adjusted recurrent VTE rates were higher for filter insertion than for no insertion (6.1% vs. 0.6%; p < 0.001).

CONCLUSIONS

In patients presenting with VTE and with a significant bleeding risk, inferior vena cava filter insertion compared with anticoagulant therapy was associated with a lower risk of PE-related death and a higher risk of recurrent VTE. However, study design limitations do not imply a causal relationship between filter insertion and outcome.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of General Internal Medicine (DAIM) > Clinic of General Internal Medicine > Centre of Competence for General Internal Medicine

UniBE Contributor:

Aujesky, Drahomir

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0735-1097

Publisher:

Elsevier

Language:

English

Submitter:

Patricia Rajaonina

Date Deposited:

05 Feb 2015 09:24

Last Modified:

05 Dec 2022 14:39

Publisher DOI:

10.1016/j.jacc.2014.01.058

PubMed ID:

24576432

Uncontrolled Keywords:

deep vein thrombosis, prognosis, pulmonary embolism, survival, vena cava filter, venous thromboembolism

BORIS DOI:

10.7892/boris.62465

URI:

https://boris.unibe.ch/id/eprint/62465

Actions (login required)

Edit item Edit item
Provide Feedback